ACTRN12607000213448招募中4 期
A 48 week trial comparing the Effect of Metformin or Internet-based Lifestyle Program Compared to Placebo on Obesity Management in Young Women.
Commonwealth Scientific Industrial Research Organisation, Human Nutrition0 个研究点目标入组 300 人开始时间: 2007年4月19日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 35 Years（—）
- 性别
- Female
入选标准
- •Overweight or obese (Body Mass Index (BMI) >25 kg/m2 and <40 kg/m2) • Available for the duration of the study (1 year)• Generally healthy with no chronic or acute diseases or disorders on medical history as outlined in the medical screening questionnaire (eg life-threatening cancer, liver disease, kidney disease)• Willing to be randomised to any experimental group• Have access to internet• Able to swallow whole tablets (up to three a day).
排除标准
- •Known cardiovascular disease, Type 1 or Type 2 diabetes, uncontrolled hypertension, a malignancy, a history of liver, kidney or respiratory disease.• Known thyroid abnormalities (hypo- and hyperthyroidism).• Being treated for eating disorders. • Receiving fertility treatment such as clomiphene citrate, gonadotrophins, In Vitro Fertilisation (IVF), or insulin-sensitising agents • Currently experiencing rapid weight loss.• Has known adverse reaction toward metformin.• Has a history of heavy alcohol consumption (>5 standard drinks/day) and unable to cease.• Pregnant or breastfeeding.
研究者
相似试验
招募中
4 期
A clinical trial involving patients with Polycystic Ovary Syndrome and to compare the effectivess of Metformin and oral contraceptives given alone or in combination to these patients.CTRI/2019/06/019879SMHS Hospital Srinagar
招募中
3 期
empagliflozin effect in polycystic ovarian syndromPolycystic ovarian syndrome.Polycystic ovarian syndromeE28.2IRCT20220822055771N1Shahre-kord University of Medical Sciences50
进行中（未招募）
不适用
A Prospective Randomised Pilot Study of Metformin and Lifestyle Intervention in the Prevention of Metabolic Syndrome due to Androgen Deprivation Therapy in Prostate Cancer - Metformin use in patients on ADT to prevent Metabolic SyndromePatients with prostate cancer on androgen deprivation therapy (ADT). Randomisation between standard treatment with ADT only, and the additional use of metformin with dietary and exercise advice.Aim is to reduce the prevalence of metabolic syndrome in the intervention arm - this is a condition linked to ADT in prostate cancer patientsMedDRA version: 9.1Level: LLTClassification code 10001186Term: Adenocarcinoma of prostateMedDRA version: 9.1Level: LLTClassification code 10052066Term: Metabolic syndromeEUCTR2007-002815-20-GBRoyal Surrey County Hospital
招募中
3 期
Impact of metformin on pregnancy outcomes in overweight womePregnancy outcomes in overweight pregnancies.IRCT20190716044229N1Oroumia University of Medical Sciences350
进行中（未招募）
1 期
A randomised study of the effect of metformin and exercise in overweight women with polycystic ovary syndrome - Metformin-exercise projectPolycystic ovary syndrome is a condition characterized by obesity, anovulation and hyperandrogenism/hyperandrogenemia. Insulin resistance is common, and treatment is aimed at reducing this.EUCTR2004-004257-26-DKOrganisation name was not entered